{"disease":{"id":"lipodystrophy-familial-partial","name":"lipodystrophy familial partial"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07090629","title":"The Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardiovascular Risk Assessment at Reunion Island.","phase":"","overall_status":"COMPLETED","enrollment_count":126,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Réunion","has_results":false},{"nct_id":"NCT04056000","title":"Lipodystrophy and Fat Metabolism During Exercise","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Exeter","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}